Detalhe da pesquisa
1.
Patient-reported function, health-related quality of life, and symptoms in APHINITY: pertuzumab plus trastuzumab and chemotherapy in HER2-positive early breast cancer.
Br J Cancer
; 125(1): 38-47, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33828257